You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AAV Vectors

Showing 1 - 25 of 208
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Seroprevalence and Seroconversion of Antibodies to

Recruiting
  • Hemophilia A
  • Blood sample collection
  • Madison, Wisconsin
    Covance Inc
Sep 16, 2022

Study in Subjects Who Received vMCO-I Administered Via

Enrolling by invitation
  • Retinitis Pigmentosa
  • +2 more
  • Gene Therapy product:vMCO-I
  • Cuttack, Odisha, India
    JPM Rotary Club of Cuttack Eye Hospital and Research Institute
Jun 26, 2023

Parkinson's Disease Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Convection enhanced

Completed
  • Parkinson's Disease
  • Convection enhanced delivery/AAV2-GDNF
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Alpha 1-Antitrypsin Deficiency Trial in Gainesville, Worcester (rAAV2-CB-hAAT Gene Vector)

Completed
  • Alpha 1-Antitrypsin Deficiency
  • rAAV2-CB-hAAT Gene Vector
  • Gainesville, Florida
  • +1 more
Apr 8, 2020

Liver Biopsy In Haemophilia Gene Therapy

Not yet recruiting
  • Hemophilia B, Severe
  • Hemophilia A, Severe
    • (no location specified)
    Mar 23, 2021

    Retinitis Pigmentosa, Retinitis, Retinal Diseases Trial in Puerto Rico, United States (Gene Therapy Product-vMCO-010, Sham

    Active, not recruiting
    • Retinitis Pigmentosa
    • +6 more
    • Gene Therapy Product-vMCO-010
    • Sham Injection
    • Beverly Hills, California
    • +6 more
    Jul 13, 2022

    Hypertriglyceridemia, Familial Trial in Nanjing (GC304)

    Not yet recruiting
    • Hypertriglyceridemia, Familial
    • GC304
    • Nanjing, China
      Affiliated Jinling Hospital, Medical School, Nanjing University
    May 5, 2023

    Squamous Cell Head Neck Cancer, Radiation Induced Xerostomia, Salivary Hypofunction Trial run by the (AAV2hAQP1)

    Recruiting
    • Squamous Cell Head and Neck Cancer
    • +2 more
    • AAV2hAQP1
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    May 3, 2022

    Non-syndromic Retinitis Pigmentosa Trial in Pittsburgh, Paris, London (Gene therapy: GS030-DP AND Medical device: GS030-MD)

    Recruiting
    • Non-syndromic Retinitis Pigmentosa
    • Gene therapy: GS030-DP AND Medical device: GS030-MD
    • Pittsburgh, Pennsylvania
    • +2 more
    Jul 25, 2022

    Bietti's Crystalline Dystrophy Trial in China (ZVS101e)

    Recruiting
    • Bietti's Crystalline Dystrophy
    • Beijing, Beijing, China
    • +3 more
    Apr 16, 2023

    Hemophilia B Trial in Washington (SB-FIX)

    Terminated
    • Hemophilia B
    • SB-FIX
    • Washington, District of Columbia
      Georgetown University Medical Center
    Mar 8, 2022

    Pompe Disease (Late-onset) Trial (No Intervention)

    Not yet recruiting
    • Pompe Disease (Late-onset)
    • No Intervention
    • (no location specified)
    Nov 21, 2023

    Pompe Disease Trial in Gainesville (genetic, drug, other)

    Completed
    • Pompe Disease
    • Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase
    • +7 more
    • Gainesville, Florida
      Clinical and Translational Research Building (CTRB), University
    Mar 24, 2022

    MPS I Trial in Oakland (SB-318)

    Terminated
    Has Results
    • MPS I
    • SB-318
    • Oakland, California
      UCSF Benioff Children's Hospital Oakland
    Jan 6, 2023

    Leber Hereditary Optic Neuropathy Trial in Worldwide (GS010, Placebo)

    Active, not recruiting
    • Leber Hereditary Optic Neuropathy
    • GS010
    • Placebo
    • Pasadena, California
    • +12 more
    Aug 2, 2022

    Liver Biopsy Following Gene Therapy For Hemophilia

    Not yet recruiting
    • Hemophilia A
    • Hemophilia B
    • Liver Biopsy
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Jun 27, 2023

    Leber Hereditary Optic Neuropathy Trial in Worldwide (GS010, Sham)

    Completed
    • Leber Hereditary Optic Neuropathy
    • GS010
    • Sham
    • Pasadena, California
    • +6 more
    Jul 25, 2022

    Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, End Stage Renal Disease Trial in France (Discontinuation (or not

    Recruiting
    • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
    • End Stage Renal Disease
    • Discontinuation (or not initiation) of Immunosuppressive Therapy
    • Maintenance (or initiation) of immunosuppressive treatment: Imurel®, Mabthera®,Cellcept®, Cortancyl®
    • Amiens, France
    • +54 more
    Jan 6, 2023

    Antineutrophil Cytoplasmic Antibody-associated Vasculitis Trial (Avacopan, Placebo, Standard of Care)

    Not yet recruiting
    • Antineutrophil Cytoplasmic Antibody-associated Vasculitis
    • (no location specified)
    Oct 6, 2023

    Avacostar - (PASS)

    Not yet recruiting
    • ANCA-associated Vasculitis
      • (no location specified)
      Jun 12, 2023

      AADC Deficiency Trial in San Francisco, Columbus (AAV2-hAADC)

      Recruiting
      • AADC Deficiency
      • San Francisco, California
      • +2 more
      Jan 14, 2022

      Bietti's Crystalline Dystrophy Trial in Beijing (ZVS101e)

      Recruiting
      • Bietti's Crystalline Dystrophy
      • Beijing, Beijing, China
        Peking University Third Hospital
      Feb 2, 2023

      Parkinson Disease Trial in United States (AAV-GAD)

      Enrolling by invitation
      • Parkinson Disease
      • AAV-GAD
      • West Bloomfield, Michigan
      • +4 more
      Jun 7, 2023

      Subclinical Cytomegalovirus Reactivation in Acute

      Recruiting
      • ANCA Associated Vasculitis
        • Birmingham, West Midlands, United Kingdom
          University Hospitals Birmingham
        Jan 15, 2023

        Age-Related Macular Degeneration Trial in Toronto (NG101 AAV gene therapy)

        Not yet recruiting
        • Age-Related Macular Degeneration
        • NG101 AAV gene therapy
        • Toronto, Ontario, Canada
          Vitreous Retina Macula Specialists of Toronto
        Aug 2, 2023